Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39,817,308
-
Total 13F shares
-
71,531
-
Share change
-
+24,405
-
Total reported value
-
$246,685
-
Price per share
-
$3.45
-
Number of holders
-
6
-
Value change
-
+$83,630
-
Number of buys
-
4
-
Number of sells
-
1
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) as of Q1 2023
As of 31 Mar 2023,
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,531 shares.
The largest 6 holders included
Centric Wealth Management, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., UBS Group AG, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.